Physician profile

Jeffrey Forman

Pulmonary Disease · Suffolk, VA

NPI 1649233917

$8,842.96

in general payments reported to CMS, 2019-2025

45 companies · $1,812 in 2025

The $1,812 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,357.13
Education$179.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $1,911.19 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Astrazeneca Pharmaceuticals LP $1,385.58 2019-2025 Airsupra, Fasenra, Breztri
Regeneron Healthcare Solutions, INC. $721.68 2022-2025 Dupixent
Genzyme Corporation $619.78 2019-2025
Boehringer Ingelheim Pharmaceuticals, INC. $619.42 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Amgen INC. $524.10 2019-2025 Tezspire
Takeda Pharmaceuticals U.S.A., INC. $246.46 2022-2025 Glassia
Baxter Healthcare $190.52 2022-2024 Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System
Mallinckrodt Hospital Products INC. $186.42 2021-2024 Acthar
Genentech USA, INC. $185.78 2019-2024 Xolair
Ani Pharmaceuticals, INC. $157.63 2023-2025 Purified Cortrophin Gel
Janssen Pharmaceuticals, INC $157.37 2019-2022
Electromed, INC. $130.80 2022-2025 Smartvest
Jazz Pharmaceuticals INC. $124.29 2021-2024
Mylan Specialty L.P. $121.28 2019-2024 Yupelri
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Actelion Pharmaceuticals US, INC. $111.41 2021-2024 Uptravi, Opsumit
Philips North America LLC $108.12 2023-2025 (Ak6) Vest Therapy, Vest Therapy Und
Merck Sharp & Dohme LLC $105.13 2021-2024 Zerbaxa, Belsomra, Keytruda
Pharming Healthcare, INC. $94.81 2022-2023 Ruconest
Pfizer INC. $91.95 2019-2025
Inogen, INC. $90.46 2022-2024 Inogen One G5 Oxygen Concentrator - Bluetooth
Sanofi-Aventis U.S. LLC $84.99 2025
Grifols USA, LLC $67.76 2020-2024 Prolastin-C Liquid
Verona Pharma, INC. $64.93 2025 Ohtuvayre
Novartis Pharmaceuticals Corporation $62.71 2019-2025
Insmed, INC. $60.85 2024-2025 Arikayce
Viatris Specialty LLC $60.12 2025 Yupelri
Teva Pharmaceuticals USA, INC. $54.88 2022
Paratek Pharmaceuticals, INC. $45.62 2022-2023 Nuzyra
Masimo Corporation $43.22 2020
Advanced Respiratory, INC $43.04 2021
Harmony Biosciences LLC $41.68 2022-2025
Novo Nordisk INC $40.95 2020-2022
United Therapeutics Corporation $38.14 2022-2025 Tyvaso
Axsome Therapeutics, INC. $35.72 2025 Sunosi
Novavax INC $28.68 2023 Novavax Covid-19 Vaccine, Adjuvanted
Breas Medical, INC. $25.90 2024 Vivo 45 Ls
Shionogi INC $22.54 2023 Fetroja
Idorsia Pharmaceuticals US INC $21.55 2023 Quviviq
Pulmonx Corporation $21.02 2024 Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console
Sunovion Pharmaceuticals INC. $20.61 2019
Abbvie INC. $19.44 2023
Vifor Pharma, INC. $19.38 2024 Zemaira
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $19.05 2023 Lifevest
Allergan, INC. $16.00 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey Forman

$8,842.96

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $1,812 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/467235/jeffrey-forman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.